List of Tables

    Table 1. Covid-19 Rapid Antigen Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Covid-19 Rapid Antigen Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of Nasal Swab

    Table 4. Major Players of Oral Fluid/Saliva

    Table 5. Global Covid-19 Rapid Antigen Sales by Type (2019-2024) & (K Units)

    Table 6. Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)

    Table 7. Global Covid-19 Rapid Antigen Revenue by Type (2019-2024) & ($ million)

    Table 8. Global Covid-19 Rapid Antigen Revenue Market Share by Type (2019-2024)

    Table 9. Global Covid-19 Rapid Antigen Sale Price by Type (2019-2024) & (US$/Unit)

    Table 10. Global Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)

    Table 11. Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)

    Table 12. Global Covid-19 Rapid Antigen Revenue by Application (2019-2024)

    Table 13. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2019-2024)

    Table 14. Global Covid-19 Rapid Antigen Sale Price by Application (2019-2024) & (US$/Unit)

    Table 15. Global Covid-19 Rapid Antigen Sales by Company (2019-2024) & (K Units)

    Table 16. Global Covid-19 Rapid Antigen Sales Market Share by Company (2019-2024)

    Table 17. Global Covid-19 Rapid Antigen Revenue by Company (2019-2024) ($ Millions)

    Table 18. Global Covid-19 Rapid Antigen Revenue Market Share by Company (2019-2024)

    Table 19. Global Covid-19 Rapid Antigen Sale Price by Company (2019-2024) & (US$/Unit)

    Table 20. Key Manufacturers Covid-19 Rapid Antigen Producing Area Distribution and Sales Area

    Table 21. Players Covid-19 Rapid Antigen Products Offered

    Table 22. Covid-19 Rapid Antigen Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 23. New Products and Potential Entrants

    Table 24. Mergers & Acquisitions, Expansion

    Table 25. Global Covid-19 Rapid Antigen Sales by Geographic Region (2019-2024) & (K Units)

    Table 26. Global Covid-19 Rapid Antigen Sales Market Share Geographic Region (2019-2024)

    Table 27. Global Covid-19 Rapid Antigen Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 28. Global Covid-19 Rapid Antigen Revenue Market Share by Geographic Region (2019-2024)

    Table 29. Global Covid-19 Rapid Antigen Sales by Country/Region (2019-2024) & (K Units)

    Table 30. Global Covid-19 Rapid Antigen Sales Market Share by Country/Region (2019-2024)

    Table 31. Global Covid-19 Rapid Antigen Revenue by Country/Region (2019-2024) & ($ millions)

    Table 32. Global Covid-19 Rapid Antigen Revenue Market Share by Country/Region (2019-2024)

    Table 33. Americas Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)

    Table 34. Americas Covid-19 Rapid Antigen Sales Market Share by Country (2019-2024)

    Table 35. Americas Covid-19 Rapid Antigen Revenue by Country (2019-2024) & ($ Millions)

    Table 36. Americas Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2024)

    Table 37. Americas Covid-19 Rapid Antigen Sales by Type (2019-2024) & (K Units)

    Table 38. Americas Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)

    Table 39. APAC Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)

    Table 40. APAC Covid-19 Rapid Antigen Sales Market Share by Region (2019-2024)

    Table 41. APAC Covid-19 Rapid Antigen Revenue by Region (2019-2024) & ($ Millions)

    Table 42. APAC Covid-19 Rapid Antigen Revenue Market Share by Region (2019-2024)

    Table 43. APAC Covid-19 Rapid Antigen Sales by Type (2019-2024) & (K Units)

    Table 44. APAC Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)

    Table 45. Europe Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)

    Table 46. Europe Covid-19 Rapid Antigen Sales Market Share by Country (2019-2024)

    Table 47. Europe Covid-19 Rapid Antigen Revenue by Country (2019-2024) & ($ Millions)

    Table 48. Europe Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2024)

    Table 49. Europe Covid-19 Rapid Antigen Sales by Type (2019-2024) & (K Units)

    Table 50. Europe Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)

    Table 51. Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)

    Table 52. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country (2019-2024)

    Table 53. Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2019-2024) & ($ Millions)

    Table 54. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country (2019-2024)

    Table 55. Middle East & Africa Covid-19 Rapid Antigen Sales by Type (2019-2024) & (K Units)

    Table 56. Middle East & Africa Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)

    Table 57. Key Market Drivers & Growth Opportunities of Covid-19 Rapid Antigen

    Table 58. Key Market Challenges & Risks of Covid-19 Rapid Antigen

    Table 59. Key Industry Trends of Covid-19 Rapid Antigen

    Table 60. Covid-19 Rapid Antigen Raw Material

    Table 61. Key Suppliers of Raw Materials

    Table 62. Covid-19 Rapid Antigen Distributors List

    Table 63. Covid-19 Rapid Antigen Customer List

    Table 64. Global Covid-19 Rapid Antigen Sales Forecast by Region (2025-2030) & (K Units)

    Table 65. Global Covid-19 Rapid Antigen Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 66. Americas Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)

    Table 67. Americas Covid-19 Rapid Antigen Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 68. APAC Covid-19 Rapid Antigen Sales Forecast by Region (2025-2030) & (K Units)

    Table 69. APAC Covid-19 Rapid Antigen Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 70. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)

    Table 71. Europe Covid-19 Rapid Antigen Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 72. Middle East & Africa Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)

    Table 73. Middle East & Africa Covid-19 Rapid Antigen Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 74. Global Covid-19 Rapid Antigen Sales Forecast by Type (2025-2030) & (K Units)

    Table 75. Global Covid-19 Rapid Antigen Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 76. Global Covid-19 Rapid Antigen Sales Forecast by Application (2025-2030) & (K Units)

    Table 77. Global Covid-19 Rapid Antigen Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 78. Abbott Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 79. Abbott Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 80. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 81. Abbott Main Business

    Table 82. Abbott Latest Developments

    Table 83. Access Bio Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 84. Access Bio Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 85. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 86. Access Bio Main Business

    Table 87. Access Bio Latest Developments

    Table 88. BD Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 89. BD Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 90. BD Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 91. BD Main Business

    Table 92. BD Latest Developments

    Table 93. Quidel Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 94. Quidel Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 95. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 96. Quidel Main Business

    Table 97. Quidel Latest Developments

    Table 98. Fujirebio Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 99. Fujirebio Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 100. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 101. Fujirebio Main Business

    Table 102. Fujirebio Latest Developments

    Table 103. Ellume Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 104. Ellume Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 105. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 106. Ellume Main Business

    Table 107. Ellume Latest Developments

    Table 108. OraSure Technologies Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 109. OraSure Technologies Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 110. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 111. OraSure Technologies Main Business

    Table 112. OraSure Technologies Latest Developments

    Table 113. Clip Health Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 114. Clip Health Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 115. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 116. Clip Health Main Business

    Table 117. Clip Health Latest Developments

    Table 118. Celltrion Healthcare Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 119. Celltrion Healthcare Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 120. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 121. Celltrion Healthcare Main Business

    Table 122. Celltrion Healthcare Latest Developments

    Table 123. Salofa Oy Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 124. Salofa Oy Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 125. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 126. Salofa Oy Main Business

    Table 127. Salofa Oy Latest Developments

    Table 128. iHealth Labs Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 129. iHealth Labs Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 130. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 131. iHealth Labs Main Business

    Table 132. iHealth Labs Latest Developments

    Table 133. Novegent Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 134. Novegent Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 135. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 136. Novegent Main Business

    Table 137. Novegent Latest Developments

    Table 138. Hangzhou Alltest Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 139. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 140. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 141. Hangzhou Alltest Biotech Main Business

    Table 142. Hangzhou Alltest Biotech Latest Developments

    Table 143. Guangzhou Decheng Biotechnology Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 144. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 145. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 146. Guangzhou Decheng Biotechnology Main Business

    Table 147. Guangzhou Decheng Biotechnology Latest Developments

    Table 148. SD Biosensor Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 149. SD Biosensor Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 150. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 151. SD Biosensor Main Business

    Table 152. SD Biosensor Latest Developments

    Table 153. MP Biomedical Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 154. MP Biomedical Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 155. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 156. MP Biomedical Main Business

    Table 157. MP Biomedical Latest Developments

    Table 158. Jiangsu Well Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 159. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 160. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 161. Jiangsu Well Biotech Main Business

    Table 162. Jiangsu Well Biotech Latest Developments

    Table 163. CTK Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 164. CTK Biotech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 165. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 166. CTK Biotech Main Business

    Table 167. CTK Biotech Latest Developments

    Table 168. Hangzhou Laihe Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 169. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 170. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 171. Hangzhou Laihe Biotech Main Business

    Table 172. Hangzhou Laihe Biotech Latest Developments

    Table 173. Innovation Scientific Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 174. Innovation Scientific Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 175. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 176. Innovation Scientific Main Business

    Table 177. Innovation Scientific Latest Developments

    Table 178. Biohit Healthcare Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 179. Biohit Healthcare Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 180. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 181. Biohit Healthcare Main Business

    Table 182. Biohit Healthcare Latest Developments

    Table 183. ACON Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 184. ACON Biotech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 185. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 186. ACON Biotech Main Business

    Table 187. ACON Biotech Latest Developments

    Table 188. Assure Tech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 189. Assure Tech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 190. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 191. Assure Tech Main Business

    Table 192. Assure Tech Latest Developments

    Table 193. Hangzhou Clongene Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 194. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 195. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 196. Hangzhou Clongene Biotech Main Business

    Table 197. Hangzhou Clongene Biotech Latest Developments

    Table 198. Hangzhou Testsea Biotechnology Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors

    Table 199. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Portfolios and Specifications

    Table 200. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 201. Hangzhou Testsea Biotechnology Main Business

    Table 202. Hangzhou Testsea Biotechnology Latest Developments

List of Figures

    Figure 1. Picture of Covid-19 Rapid Antigen

    Figure 2. Covid-19 Rapid Antigen Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Covid-19 Rapid Antigen Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Covid-19 Rapid Antigen Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Covid-19 Rapid Antigen Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of Nasal Swab

    Figure 10. Product Picture of Oral Fluid/Saliva

    Figure 11. Global Covid-19 Rapid Antigen Sales Market Share by Type in 2023

    Figure 12. Global Covid-19 Rapid Antigen Revenue Market Share by Type (2019-2024)

    Figure 13. Covid-19 Rapid Antigen Consumed in Hospitals

    Figure 14. Global Covid-19 Rapid Antigen Market: Hospitals (2019-2024) & (K Units)

    Figure 15. Covid-19 Rapid Antigen Consumed in Scientific Research

    Figure 16. Global Covid-19 Rapid Antigen Market: Scientific Research (2019-2024) & (K Units)

    Figure 17. Global Covid-19 Rapid Antigen Sales Market Share by Application (2023)

    Figure 18. Global Covid-19 Rapid Antigen Revenue Market Share by Application in 2023

    Figure 19. Covid-19 Rapid Antigen Sales Market by Company in 2023 (K Units)

    Figure 20. Global Covid-19 Rapid Antigen Sales Market Share by Company in 2023

    Figure 21. Covid-19 Rapid Antigen Revenue Market by Company in 2023 ($ Million)

    Figure 22. Global Covid-19 Rapid Antigen Revenue Market Share by Company in 2023

    Figure 23. Global Covid-19 Rapid Antigen Sales Market Share by Geographic Region (2019-2024)

    Figure 24. Global Covid-19 Rapid Antigen Revenue Market Share by Geographic Region in 2023

    Figure 25. Americas Covid-19 Rapid Antigen Sales 2019-2024 (K Units)

    Figure 26. Americas Covid-19 Rapid Antigen Revenue 2019-2024 ($ Millions)

    Figure 27. APAC Covid-19 Rapid Antigen Sales 2019-2024 (K Units)

    Figure 28. APAC Covid-19 Rapid Antigen Revenue 2019-2024 ($ Millions)

    Figure 29. Europe Covid-19 Rapid Antigen Sales 2019-2024 (K Units)

    Figure 30. Europe Covid-19 Rapid Antigen Revenue 2019-2024 ($ Millions)

    Figure 31. Middle East & Africa Covid-19 Rapid Antigen Sales 2019-2024 (K Units)

    Figure 32. Middle East & Africa Covid-19 Rapid Antigen Revenue 2019-2024 ($ Millions)

    Figure 33. Americas Covid-19 Rapid Antigen Sales Market Share by Country in 2023

    Figure 34. Americas Covid-19 Rapid Antigen Revenue Market Share by Country in 2023

    Figure 35. Americas Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)

    Figure 36. Americas Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)

    Figure 37. United States Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 38. Canada Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 39. Mexico Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 40. Brazil Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 41. APAC Covid-19 Rapid Antigen Sales Market Share by Region in 2023

    Figure 42. APAC Covid-19 Rapid Antigen Revenue Market Share by Regions in 2023

    Figure 43. APAC Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)

    Figure 44. APAC Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)

    Figure 45. China Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 46. Japan Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 47. South Korea Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 48. Southeast Asia Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 49. India Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 50. Australia Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 51. China Taiwan Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 52. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2023

    Figure 53. Europe Covid-19 Rapid Antigen Revenue Market Share by Country in 2023

    Figure 54. Europe Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)

    Figure 55. Europe Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)

    Figure 56. Germany Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 57. France Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 58. UK Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 59. Italy Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 60. Russia Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 61. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country in 2023

    Figure 62. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country in 2023

    Figure 63. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)

    Figure 64. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)

    Figure 65. Egypt Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 66. South Africa Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 67. Israel Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 68. Turkey Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 69. GCC Country Covid-19 Rapid Antigen Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen in 2023

    Figure 71. Manufacturing Process Analysis of Covid-19 Rapid Antigen

    Figure 72. Industry Chain Structure of Covid-19 Rapid Antigen

    Figure 73. Channels of Distribution

    Figure 74. Global Covid-19 Rapid Antigen Sales Market Forecast by Region (2025-2030)

    Figure 75. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Region (2025-2030)

    Figure 76. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Type (2025-2030)

    Figure 77. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Type (2025-2030)

    Figure 78. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Application (2025-2030)

    Figure 79. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Application (2025-2030)